Published in Neurosci Lett on October 10, 1985
Sequence and functional expression of the GABA A receptor shows a ligand-gated receptor super-family. Nature (1987) 5.12
Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science (1976) 4.07
Structural and functional basis for GABAA receptor heterogeneity. Nature (1988) 2.65
Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes. Mol Pharmacol (1976) 2.09
Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency. Nature (1976) 1.71
Ethanol sensitivity of the GABAA receptor expressed in Xenopus oocytes requires 8 amino acids contained in the gamma 2L subunit. Neuron (1991) 1.36
Dopamine receptor binding in the corpus striatum of mammalian brain. Proc Natl Acad Sci U S A (1975) 1.29
The dopamine receptor: differential binding of d-LSD and related agents to agonist and antagonist states. Life Sci (1975) 1.29
Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science (1977) 1.24
AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor. J Pharmacol Exp Ther (1999) 1.19
Generation of two forms of the gamma-aminobutyric acidA receptor gamma 2-subunit in mice by alternative splicing. J Neurochem (1991) 1.18
Immortalized human corneal epithelial cells for ocular toxicity and inflammation studies. Invest Ophthalmol Vis Sci (1999) 1.18
Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. Science (1977) 1.16
The pharmacological properties of the peptide, endothelin. Br J Pharmacol (1989) 1.12
Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs. Arch Ophthalmol (1999) 1.04
Pharmacological characterization of an FP prostaglandin receptor on rat vascular smooth muscle cells (A7r5) coupled to phosphoinositide turnover and intracellular calcium mobilization. J Pharmacol Exp Ther (1998) 0.98
PD117302: a selective agonist for the kappa-opioid receptor. Br J Pharmacol (1988) 0.96
Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptor. Br J Pharmacol (2000) 0.96
Thyrotropin releasing hormone (TRH): apparent receptor binding in rat brain membranes. Brain Res (1975) 0.95
Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat. Br J Pharmacol (1995) 0.95
Transcriptional regulation of GABAA receptor gamma2 subunit gene. Brain Res Mol Brain Res (1999) 0.94
Dopamine receptor binding: differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol. Life Sci (1975) 0.94
Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist. J Ocul Pharmacol Ther (2001) 0.93
Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: pharmacological characterization using agonists and antagonists. Br J Pharmacol (1999) 0.93
Rho-Rho kinase pathway in the actomyosin contraction and cell-matrix adhesion in immortalized human trabecular meshwork cells. Mol Vis (2011) 0.92
Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization. Invest Ophthalmol Vis Sci (1997) 0.89
Quantitative autoradiographic visualization and pharmacology of FP-prostaglandin receptors in human eyes using the novel phosphor-imaging technology. J Ocul Pharmacol Ther (1999) 0.89
GABAA receptor beta 1, beta 2, and beta 3 subunits: comparisons in DBA/2J and C57BL/6J mice. Biochim Biophys Acta (1995) 0.88
Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells. Ann Allergy Asthma Immunol (1997) 0.87
Dopamine D2-receptors mediate hypothermia in mice: ICV and IP effects of agonists and antagonists. Neurochem Res (1991) 0.87
Endogenous EP4 prostaglandin receptors coupled positively to adenylyl cyclase in Chinese hamster ovary cells: pharmacological characterization. Prostaglandins Leukot Essent Fatty Acids (2000) 0.87
FP prostaglandin receptors mediating inositol phosphates generation and calcium mobilization in Swiss 3T3 cells: a pharmacological study. J Pharmacol Exp Ther (1997) 0.86
Phospholipid turnover during cell-cycle traverse in synchronous Chinese-hamster ovary cells. Mitogenesis without phosphoinositide breakdown. Biochem J (1988) 0.86
Effects of l-glutamate and related amino acids upon the release of [3H]dopamine from rat striatal slices. Brain Res (1978) 0.86
Dopamine receptors and average clinical doses. Science (1976) 0.86
Parasympathetic denervation decreases muscarinic receptor binding in rat parotid. Life Sci (1979) 0.85
Characterization of recombinant GABAA receptors produced in transfected cells from murine alpha 1, beta 1, and gamma 2 subunit cDNAs. Neurosci Lett (1991) 0.85
Characterization and autoradiographic localization of TRH receptors in sections of rat brain. Brain Res (1984) 0.84
Benzodiazepines compete for thyrotropin-releasing hormone receptor binding: micromolar potency in rat pituitary, retina and amygdala. Neurosci Lett (1983) 0.84
The brain's dopamine receptor: labeling with (3H) dopamine and (3H) haloperidol. Psychopharmacol Commun (1975) 0.84
Ontogenesis of dopamine receptor binding in the corpus striatum of the rat. Brain Res (1977) 0.84
Differential expression of two forms of GABAA receptor gamma 2-subunit in mice. Brain Res Bull (1991) 0.84
Binding interactions of lysergic acid diethylamide and related agents with dopamine receptors in the brain. Mol Pharmacol (1976) 0.83
The mouse GABA(A) receptor alpha3 subunit gene and promoter. Brain Res Mol Brain Res (1999) 0.83
Species differences in the brain regional distribution of receptor binding for thyrotropin-releasing hormone. J Neurochem (1982) 0.83
Problems associated with the binding of L-glutamic acid to synaptic membranes: methodological aspects. J Neurochem (1980) 0.82
Binding sites for thyrotropin-releasing hormone in sheep nucleus accumbens resemble pituitary receptors. Endocrinology (1980) 0.82
Codepletion of serotonin and TRH induces apparent supersensitivity of spinal TRH receptors. Eur J Pharmacol (1983) 0.81
The influence of muscle-conditioned medium on cholinergic maturation in spinal cord cell cultures. Brain Res (1980) 0.81
Rat brain TRH receptors: kinetics, pharmacology, distribution and ionic effects. Regul Pept (1983) 0.81
Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. J Neuropsychiatry Clin Neurosci (1996) 0.81
Effects of bradykinin on signal transduction, cell proliferation, and cytokine, prostaglandin E2 and collagenase-1 release from human corneal epithelial cells. Br J Pharmacol (1998) 0.81
Muscarinic M3 receptors mediate total inositol phosphates accumulation in murine HSDM1C1 fibrosarcoma cells. Eur J Pharmacol (1993) 0.80
Comparison of the Leicester Micropalliator and the Cardiff Palliator in the relief of postoperative pain. Br J Anaesth (1987) 0.80
Induction of RANTES chemokine expression in human astrocytic cells is dependent upon activation of NF-kappaB transcription factor. Int J Mol Med (2001) 0.80
Sulfhydryl groups in receptor binding of thyrotropin-releasing hormone to rat amygdala. J Neurochem (1984) 0.80
Striatal glutamatergic function: modifications following specific lesions. Brain Res (1982) 0.80
Characteristics of [3H]5-hydroxytryptamine binding to iris-ciliary body tissue of the rabbit. Invest Ophthalmol Vis Sci (1995) 0.80
The effects of elevated glucose on Na+/K(+)-ATPase of cultured bovine retinal pigment epithelial cells measured by a new nonradioactive rubidium uptake assay. J Ocul Pharmacol Ther (1997) 0.79
Muscarinic receptor binding in sheep anterior pituitary. Neuroendocrinology (1980) 0.79
The alpha 1, alpha 2, and alpha 3 subunits of GABAA receptors: comparison in seizure-prone and -resistant mice and during development. J Mol Neurosci (1992) 0.79
The expression of functionally-coupled B2-bradykinin receptors in human corneal epithelial cells and their pharmacological characterization with agonists and antagonists. Br J Pharmacol (1997) 0.79
Prostaglandin-stimulated adenylyl cyclase activity via a pharmacologically defined EP2 receptor in human nonpigmented ciliary epithelial cells. J Ocul Pharmacol Ther (1998) 0.79
Use of a semi-automated, robotic radioimmunoassay to measure cAMP generated by activation of DP-, EP2-, and IP-prostaglandin receptors in human ocular and other cell types. Prostaglandins Leukot Essent Fatty Acids (1998) 0.79
GABA(A) receptor alpha4 subunit in DBA/2J and C57BL/6J mice. Brain Res Bull (1998) 0.78
L-Aspartate binding sites in rat cerebellum: a comparison of the binding of L-[3H]aspartate and L-[3H]glutamate to synaptic membranes. Brain Res (1981) 0.78
Ovarian steroids modulate the release of dopamine into hypophysial portal blood and the density of anterior pituitary [3H]spiperone-binding sites in ovariectomized rats. Endocrinology (1984) 0.78
Axotomy in rat sympathetic ganglia: reciprocal effects on muscarinic receptor binding and 6-phosphogluconate dehydrogenase activity. Brain Res (1979) 0.78
Phosphonate analogues of acidic amino acids: inhibition of excitatory amino acid transmitter binding to cerebellar membranes and of the stimulation of cerebellar cyclic GMP levels. Brain Res (1982) 0.78
Pituitary cell cultures contain muscarinic receptors. Eur J Pharmacol (1980) 0.78
Regulation of cerebellar L-[3H]glutamate binding: influence of guanine nucleotides and Na+ ions. Biochem Pharmacol (1981) 0.78
[(3)H]-serotonin release from bovine iris-ciliary body: pharmacology of prejunctional serotonin (5-HT(7)) autoreceptors. Exp Eye Res (2001) 0.77
Neurochemical, pharmacological, and developmental studies on cerebellar receptors for dicarboxylic amino acids. Neurochem Res (1984) 0.77
Muscarinic receptor binding in rat sympathetic ganglia is unaffected by denervation. Brain Res (1978) 0.77
Guanine nucleotides modulate TRH-receptor binding in sheep anterior pituitary. Mol Cell Endocrinol (1981) 0.77
Hypoxia-induced [(3)H]D-aspartate release from isolated bovine retina: modulation by calcium-channel blockers and glutamatergic agonists and antagonists. Curr Eye Res (2001) 0.77
A PCR shortcut to oocyte expression. Biotechniques (1993) 0.77
Glatiramer acetate inhibition of tumor necrosis factor-alpha-induced RANTES expression and release from U-251 MG human astrocytic cells. J Neurochem (2001) 0.77
Multiple synaptic receptors for neuroactive amino acid transmitters--new vistas. Int Rev Neurobiol (1985) 0.77
Preparation of 3H-[3-M3-His2]TRH as an improved ligand for TRH receptors. Neuroendocrinology (1981) 0.77
Flow cytometric analysis of internal calcium mobilization via a B2-bradykinin receptor on a subclone of PC-12 cells. J Neurochem (1991) 0.77
Micromolar substance P reduces spinal receptor binding for thyrotropin-releasing hormone--possible relevance to neuropeptide coexistence? Neurosci Lett (1983) 0.77
TRH receptor binding in retina and pituitary: major species variation. Exp Eye Res (1982) 0.76
Neurotransmitter receptor binding: regional distribution in human brain. J Neurochem (1977) 0.76
Muscarinic receptors in the posterior pituitary gland. Neuroendocrinology (1981) 0.76
A synthetic standard for competitive RT-PCR quantitation of 13 GABA receptor type A subunit mRNAs in rats and mice. J Neurosci Methods (1998) 0.76
The use of spinal cord cell cultures in the study of neurotoxicological agents. Toxicology (1980) 0.76
Biochemical similarity of rat pituitary and CNS TRH receptors. Neurosci Lett (1983) 0.76
Modulation of receptors for thyrotropin-releasing hormone by benzodiazepines: brain regional differences. J Neurochem (1984) 0.76
Receptors for thyrotropin-releasing hormone (TRH) in rabbit spinal cord. Brain Res (1983) 0.76
Thyrotropin-releasing hormone gene expression and receptors are differentially modified in limbic foci by seizures. Ann Neurol (1993) 0.76
Experimental spinal cord injury: effects of trauma or ischemia on TRH and muscarinic receptors. Neurology (1986) 0.76
The alpha5 subunit of the murine type A GABA receptor. Brain Res Mol Brain Res (1998) 0.76